Clinical Trial Update: Osteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis

View source ↗

Summary

A completed clinical trial evaluated procalcitonin as a diagnostic and monitoring biomarker for osteomyelitis, particularly in patients with diabetes and foot u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Foot Ulcer
• Osteomyelitis

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Diabetes, Foot Ulcer | Status: COMPLETED